Segantii Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Segantii Capital Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-200,000	Closed	-$9.29M	–	227
2023 Q2	$9.29M	Buy	+200,000	New	+$6.91M	0.48%	48

Segantii Capital Management's DICE Position: Q3 2023 in Review

Segantii Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 200,000 shares — an estimated $9.29M sold.

Segantii Capital Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $9.29M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Segantii Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Segantii Capital Management sold 200,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $9.29M.
Segantii Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Segantii Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $9.29M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Segantii Capital Management's 13F filing for Q3 2023, filed 7 Nov 2023.